Evaluation of Efficacy and Safety of Alcarisa (Hyaluronic Acid Produced by Espad Pharmed Co.) for Restoration of Mid-face Volume

Clinical trial NCT07126912 · RECRUITING

Trial details

NCT number: NCT07126912
Sponsor: Espad Pharmed
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Mid Face Volume Deficit

Start date: 2025-01-28
Primary completion: 2025-04-28
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.